Valuation: Medios AG

Market Cap 301M 344M 278M 255M 483M 33.17B 492M 3.32B 1.3B 16.2B 1.29B 1.26B 55.93B P/E 2026 *
11.1x
P/E 2027 * 8.79x
Enterprise Value 377M 431M 349M 320M 606M 41.57B 616M 4.16B 1.63B 20.3B 1.62B 1.58B 70.08B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+1.47%
1 week+3.45%
Current month+4.14%
1 month-0.47%
3 months-3.23%
6 months-16.58%
Current year-13.12%
1 week 11.84
Extreme 11.84
12.58
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
2/4/26 A Sell

Chief Executive Officer

13,638 0.0535%
1/22/26 A Buy

Executive/Senior Manager

4,000 0.0157%
8/19/24 A Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
+2.44%+3.45%0.00%-27.28% 344M
+1.16%-3.24%+49.08%+163.33% 1,031B
+0.60%-3.70%+51.42%+56.86% 595B
+3.00%+0.82%+32.20%+86.86% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+1.03%-0.84%+29.58%+45.15% 277B
+0.49%-5.44%+21.00%+23.80% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+2.67%+1.37%+23.27%+61.78% 193B
+1.75%-0.96%+21.57%+72.35% 164B
Average +1.38%-3.13%+23.50%+46.91% 350.46B
Weighted average by Cap. +1.28%-4.31%+34.64%+80.36%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.77B 3.34B 229B 3.4B 22.96B 9.02B 112B 8.94B 8.75B 387B 2.14B 2.45B 1.98B 1.81B 3.43B 236B 3.49B 23.58B 9.26B 115B 9.19B 8.98B 397B
Net income 27.41M 31.35M 25.35M 23.26M 44.02M 3.02B 44.78M 302M 119M 1.48B 118M 115M 5.09B 34.51M 39.48M 31.91M 29.28M 55.42M 3.8B 56.39M 381M 150M 1.86B 148M 145M 6.41B
Net Debt 76.15M 87.12M 70.43M 64.63M 122M 8.39B 124M 840M 330M 4.1B 327M 320M 14.15B 40.72M 46.59M 37.66M 34.56M 65.41M 4.49B 66.54M 449M 176M 2.19B 175M 171M 7.57B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
16/07/26 12.58 +2.44% 15,866
15/07/26 €12.28 +1.32% 7,634
14/07/26 €12.12 -0.16% 12,077
13/07/26 €12.14 +1.17% 26,461
10/07/26 €12.00 -1.32% 23,617
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.28EUR
Average target price
23.00EUR
Spread / Average Target
+87.30%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock